Loading...
Neutra Corp.
NTRR•PNK
Healthcare
Biotechnology
$0.00
$0.00(0.00%)
Neutra Corp. (NTRR) Financial Performance & Statements
Review Neutra Corp.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-41.86%
↓ 41.86%
Operating Income Growth
22.91%
↑ 22.91%
Net Income Growth
58.42%
↑ 58.42%
Operating Cash Flow Growth
93.25%
↑ 93.25%
Operating Margin
-110.08%
↓ 110.08%
Gross Margin
70.43%
↑ 70.43%
Net Profit Margin
-113.80%
↓ 113.80%
ROE
10.77%
↑ 10.77%
ROIC
10.03%
↑ 10.03%
Neutra Corp. (NTRR) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Neutra Corp. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $32375.00 | $28056.00 | $1311.00 | $4325.00 |
| Cost of Revenue | $1420.00 | $25219.00 | $722.00 | $2643.00 |
| Gross Profit | $30955.00 | $2837.00 | $589.00 | $1682.00 |
| Gross Profit Ratio | $0.96 | $0.10 | $0.45 | $0.39 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $45319.00 | $36618.00 | $44266.00 | $60412.00 |
| Operating Expenses | $46440.00 | $36618.00 | $53317.00 | $73451.00 |
| Total Costs & Expenses | $47860.00 | $61837.00 | $54039.00 | $76094.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $29.00 |
| Interest Expense | $867.00 | $854.00 | $2258.00 | $29.00 |
| Depreciation & Amortization | $1121.00 | $6423.00 | $9051.00 | $13039.00 |
| EBITDA | -$14364.00 | -$27358.00 | -$43677.00 | -$58730.00 |
| EBITDA Ratio | -$0.44 | -$0.98 | -$33.32 | -$13.58 |
| Operating Income | -$15485.00 | -$33780.00 | -$52728.00 | -$71769.00 |
| Operating Income Ratio | -$0.48 | -$1.20 | -$40.22 | -$16.59 |
| Other Income/Expenses (Net) | -$867.00 | -$854.00 | -$2258.00 | -$29.00 |
| Income Before Tax | -$16352.00 | -$34635.00 | -$54986.00 | -$71798.00 |
| Income Before Tax Ratio | -$0.51 | -$1.23 | -$41.94 | -$16.60 |
| Income Tax Expense | $0.00 | $1.00 | $0.00 | $49.00 |
| Net Income | -$16352.00 | -$34636.00 | -$54986.00 | -$71847.00 |
| Net Income Ratio | -$0.51 | -$1.23 | -$41.94 | -$16.61 |
| EPS | $0.00 | $0.00 | $0.00 | $0.00 |
| Diluted EPS | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Avg Shares Outstanding | $2.92B | $2.92B | $2.92B | $2.92B |
| Weighted Avg Shares Outstanding (Diluted) | $2.92B | $2.92B | $2.92B | $2.92B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan